Targeting insulin-like growth factor-binding protein-3 by microRNA-125b promotes tumor invasion and poor outcomes in non-small-cell lung cancer

Insulin-like growth factor-binding protein-3 acts as a tumor suppressor that inhibits the PI3K/AKT signaling pathway due to blocking insulin growth factor-1 binding to its receptor. We hypothesized that insulin-like growth factor-binding protein-3 might be targeted by microRNA-125b and promote tumor...

Full description

Saved in:
Bibliographic Details
Main Authors: Hsiu-Hua Wang, Yao-Chen Wang, De-Wei Wu, Chin-Sheng Hung, Chih-Yi Chen, Huei Lee
Format: Article
Language:English
Published: SAGE Publishing 2017-04-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317694316
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850112067607986176
author Hsiu-Hua Wang
Yao-Chen Wang
De-Wei Wu
Chin-Sheng Hung
Chih-Yi Chen
Huei Lee
author_facet Hsiu-Hua Wang
Yao-Chen Wang
De-Wei Wu
Chin-Sheng Hung
Chih-Yi Chen
Huei Lee
author_sort Hsiu-Hua Wang
collection DOAJ
description Insulin-like growth factor-binding protein-3 acts as a tumor suppressor that inhibits the PI3K/AKT signaling pathway due to blocking insulin growth factor-1 binding to its receptor. We hypothesized that insulin-like growth factor-binding protein-3 might be targeted by microRNA-125b and promote tumor invasion and poor outcome in non-small-cell lung cancer via activation of the PI3K/AKT signaling pathway. Real-time polymerase chain reaction and immunohistochemistry were performed to determine the level of microRNA-125b, insulin-like growth factor-binding protein-3 messenger RNA, and phosphorylated-AKT expression in 105 tumors from non-small-cell lung cancer patients. Low insulin-like growth factor-binding protein-3 messenger RNA levels and positive phosphorylated-AKT expression were more commonly found in patients with high microRNA-125b tumors than low microRNA-125b tumors. A poorer overall survival and relapse-free survival were observed in patients with high microRNA-125b tumors than low-microRNA-125b tumors in p53-mutated patients, but not in p53-wild-type patients. Mechanistically, microRNA-125b promotes invasion ability in p53-mutated cells via the PI3K/AKT activation by targeting of insulin-like growth factor-binding protein-3, but this effect was not observed in p53-wild-type cells. An increase in phosphorylated-AKT expression due to targeting of insulin-like growth factor-binding protein-3 by microRNA-125b was responsible for cell invasion in p53-mutated cells. In conclusion, the microRNA-125b level promotes invasive ability in p53-mutated cells via PI3K/AKT activation by targeting of insulin-like growth factor-binding protein-3, thereby resulting in p53-mutated non-small-cell lung cancer patients with poor outcomes.
format Article
id doaj-art-2fd0857afd6143cf93077b72caa3e0a3
institution OA Journals
issn 1423-0380
language English
publishDate 2017-04-01
publisher SAGE Publishing
record_format Article
series Tumor Biology
spelling doaj-art-2fd0857afd6143cf93077b72caa3e0a32025-08-20T02:37:29ZengSAGE PublishingTumor Biology1423-03802017-04-013910.1177/1010428317694316Targeting insulin-like growth factor-binding protein-3 by microRNA-125b promotes tumor invasion and poor outcomes in non-small-cell lung cancerHsiu-Hua Wang0Yao-Chen Wang1De-Wei Wu2Chin-Sheng Hung3Chih-Yi Chen4Huei Lee5Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, TaiwanDepartment of Internal Medicine, Chung Shan Medical University Hospital, Taichung, TaiwanGraduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, TaiwanCancer Research Center, Taipei Medical University Hospital, Taipei, TaiwanDepartment of Surgery, Chung Shan Medical University Hospital, Taichung, TaiwanGraduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, TaiwanInsulin-like growth factor-binding protein-3 acts as a tumor suppressor that inhibits the PI3K/AKT signaling pathway due to blocking insulin growth factor-1 binding to its receptor. We hypothesized that insulin-like growth factor-binding protein-3 might be targeted by microRNA-125b and promote tumor invasion and poor outcome in non-small-cell lung cancer via activation of the PI3K/AKT signaling pathway. Real-time polymerase chain reaction and immunohistochemistry were performed to determine the level of microRNA-125b, insulin-like growth factor-binding protein-3 messenger RNA, and phosphorylated-AKT expression in 105 tumors from non-small-cell lung cancer patients. Low insulin-like growth factor-binding protein-3 messenger RNA levels and positive phosphorylated-AKT expression were more commonly found in patients with high microRNA-125b tumors than low microRNA-125b tumors. A poorer overall survival and relapse-free survival were observed in patients with high microRNA-125b tumors than low-microRNA-125b tumors in p53-mutated patients, but not in p53-wild-type patients. Mechanistically, microRNA-125b promotes invasion ability in p53-mutated cells via the PI3K/AKT activation by targeting of insulin-like growth factor-binding protein-3, but this effect was not observed in p53-wild-type cells. An increase in phosphorylated-AKT expression due to targeting of insulin-like growth factor-binding protein-3 by microRNA-125b was responsible for cell invasion in p53-mutated cells. In conclusion, the microRNA-125b level promotes invasive ability in p53-mutated cells via PI3K/AKT activation by targeting of insulin-like growth factor-binding protein-3, thereby resulting in p53-mutated non-small-cell lung cancer patients with poor outcomes.https://doi.org/10.1177/1010428317694316
spellingShingle Hsiu-Hua Wang
Yao-Chen Wang
De-Wei Wu
Chin-Sheng Hung
Chih-Yi Chen
Huei Lee
Targeting insulin-like growth factor-binding protein-3 by microRNA-125b promotes tumor invasion and poor outcomes in non-small-cell lung cancer
Tumor Biology
title Targeting insulin-like growth factor-binding protein-3 by microRNA-125b promotes tumor invasion and poor outcomes in non-small-cell lung cancer
title_full Targeting insulin-like growth factor-binding protein-3 by microRNA-125b promotes tumor invasion and poor outcomes in non-small-cell lung cancer
title_fullStr Targeting insulin-like growth factor-binding protein-3 by microRNA-125b promotes tumor invasion and poor outcomes in non-small-cell lung cancer
title_full_unstemmed Targeting insulin-like growth factor-binding protein-3 by microRNA-125b promotes tumor invasion and poor outcomes in non-small-cell lung cancer
title_short Targeting insulin-like growth factor-binding protein-3 by microRNA-125b promotes tumor invasion and poor outcomes in non-small-cell lung cancer
title_sort targeting insulin like growth factor binding protein 3 by microrna 125b promotes tumor invasion and poor outcomes in non small cell lung cancer
url https://doi.org/10.1177/1010428317694316
work_keys_str_mv AT hsiuhuawang targetinginsulinlikegrowthfactorbindingprotein3bymicrorna125bpromotestumorinvasionandpooroutcomesinnonsmallcelllungcancer
AT yaochenwang targetinginsulinlikegrowthfactorbindingprotein3bymicrorna125bpromotestumorinvasionandpooroutcomesinnonsmallcelllungcancer
AT deweiwu targetinginsulinlikegrowthfactorbindingprotein3bymicrorna125bpromotestumorinvasionandpooroutcomesinnonsmallcelllungcancer
AT chinshenghung targetinginsulinlikegrowthfactorbindingprotein3bymicrorna125bpromotestumorinvasionandpooroutcomesinnonsmallcelllungcancer
AT chihyichen targetinginsulinlikegrowthfactorbindingprotein3bymicrorna125bpromotestumorinvasionandpooroutcomesinnonsmallcelllungcancer
AT hueilee targetinginsulinlikegrowthfactorbindingprotein3bymicrorna125bpromotestumorinvasionandpooroutcomesinnonsmallcelllungcancer